MK
Mohammed Khalid Aldoori
About Mohammed Khalid Aldoori
Data last updated:
Mohammed Khalid Aldoori is a Director at S. Zhaveri Pharmakem Private Limited (since 2024) and Director at Crescent R&D Private Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹49.47 Cr; the largest is S. Zhaveri Pharmakem Private Limited at ₹34.80 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 S. Zhaveri Pharmakem Private Limited U51397MH2005PTC153790 | Director | 30 May 2024 | 2005 | ₹34.80 Cr (FY 2025) | Active |
 Crescent R&D Private Limited U74900TN2014PTC096380 | Director | 10 May 2023 | 2014 | ₹14.67 Cr (FY 2024) | Active |
Board colleagues of Mohammed Khalid Aldoori
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anish Rajesh Parmar | 10727022 | S. Zhaveri Pharmakem Private Limited | Director |
| Laith Khalid Aldoori | 10098000 | S. Zhaveri Pharmakem Private Limited , Crescent R&D Private Limited | Director |
| Samie Mohammed Aldoori | 10098004 | S. Zhaveri Pharmakem Private Limited , Crescent R&D Private Limited | Director |
| Ravin Pawar | 10748739 | Crescent R&D Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammed Khalid Aldoori
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammed Khalid Aldoori
Mohammed Khalid Aldoori currently holds 2 directorships: S. Zhaveri Pharmakem Private Limited (Director, since 30 May 2024, revenue ₹34.80 Cr (FY 2025)); Crescent R&D Private Limited (Director, since 10 May 2023, revenue ₹14.67 Cr (FY 2024)).
Mohammed Khalid Aldoori was first appointed on 10 May 2023 as Director at Crescent R&D Private Limited. The most recent appointment on record is 30 May 2024 at S. Zhaveri Pharmakem Private Limited.
The 2 current companies of Mohammed Khalid Aldoori that report revenue have a combined latest revenue of ₹49.47 Cr: S. Zhaveri Pharmakem Private Limited ₹34.80 Cr (FY 2025); Crescent R&D Private Limited ₹14.67 Cr (FY 2024).
The current boards of Mohammed Khalid Aldoori's companies include Anish Rajesh Parmar (S. Zhaveri Pharmakem Private Limited), Laith Khalid Aldoori (S. Zhaveri Pharmakem Private Limited), Samie Mohammed Aldoori (S. Zhaveri Pharmakem Private Limited), Ravin Pawar (Crescent R&D Private Limited).